Augmentation of antibacterial activity of ciprofloxacin by bisabololoxide A encapsulated in polymeric nanoparticles against uropathogenic Escherichia coli
Open Access
- 15 December 2025
- journal article
- Published by Springer Nature in BMC Biotechnology
- Vol. 25 (1) , 140
Abstract
Multidrug-resistant uropathogenic Escherichia coli (UPEC) are a major cause of urinary tract infections, largely due to efflux pump overexpression, porin alterations, and increasing biofilm formation. To address these challenges, we developed bisabololoxide A-loaded PEG400-oleate polymeric nanoparticles (BAPNs) and evaluated their potential to enhance the efficacy of ciprofloxacin against ciprofloxacin-resistant isolates. BAPNs were synthesized and characterized by FTIR, TEM, FE-SEM, EDX, TGA, and zeta potential analysis. The synergistic effects of BAPNs and ciprofloxacin were evaluated in drug-resistant isolates. The inhibition of Biofilm formationwas quantified by crystal violet staining and gene expression changes in some genes related to efflux pumps, porins and biofilm formation were analyzed in two representative isolates by qPCR. BAPNs exhibited a spherical morphology with sizes ranging from 17 to 28 nm (TEM) and 30–43 nm (FE-SEM). Checkerboard analysis showed that the MIC of ciprofloxacin decreased by 2- to 32-fold in ciprofloxacin-resistant isolates and the ATCC 8739 strain when combined with BAPNs. Biofilm inhibition was significantly enhanced with the combined therapy compared to ciprofloxacin alone. qPCR analysis further revealed significant downregulation of the AcrAB-TolC efflux pump genes and the virulence genes fimH and hlyA, along with upregulation of the porin genes (ompC and ompF). Furthermore, molecular docking analysis confirmed the strong binding affinities of bisabololoxide A with virulence-associated proteins of E. coli. Our findings suggested that BAPNs may significantly potentiate ciprofloxacin activity by inhibiting efflux pump expression and biofilm formation, and increase of cell membrane permeability to drugs (with enhancing porins), thereby restoring susceptibility in resistant UPEC isolates. These results highlight BAPNs as a promising adjunctive nanocarrier strategy to overcome ciprofloxacin resistance in uropathogenic E. coli. Further validation in larger isolate panels and in vivo studies is warranted. The online version contains supplementary material available at 10.1186/s12896-025-01070-5.Keywords
This publication has 63 references indexed in Scilit:
- Antibacterial and Anti-cancer Properties of Curcumin-Functionalized Silica-Coated Fe3O4 Magnetic NanoparticlesArabian Journal for Science and Engineering, 2024
- Determining the potential targets of silybin by molecular docking and its antibacterial functions on efflux pumps and porins in uropathogenic E. coliInternational Microbiology, 2024
- In vitro and in silico assessment of anti-quorum sensing activity of Naproxen against Pseudomonas aeruginosaWorld Journal of Microbiology and Biotechnology, 2023
- Force Fields for Small Molecules2019
- Silibinin encapsulation in polymersome: A promising anticancer nanoparticle for inducing apoptosis and decreasing the expression level of miR‐125b/miR‐182 in human breast cancer cellsJournal of Cellular Physiology, 2019
- Fabrication of novel PHB-liposome nanoparticles and study of their toxicity in vitroJournal of Nanoparticle Research, 2019
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Iterative partial equalization of orbital electronegativity—a rapid access to atomic chargesTetrahedron, 1980
- The protein data bank: A computer-based archival file for macromolecular structuresArchives of Biochemistry and Biophysics, 1978